These three of the best Dividend Aristocrats to buy now with $1,000 as they all trade for less than $25 per share.

Johnson & Johnson (NYSE:JNJ) is one of the 12 stocks that will make you rich in 10 years. On June 23, J&J announced new data ...

A federal judge ruled that the government did not violate the law in a dispute with J&J over the 340B drug discount program.

Mounjaro is one of the bestselling weight loss drugs. See what your options are if you want to invest in Mounjaro stock.

Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them.

Webcast and conference call to be held on Monday, June 30th at 4:30 pm ET, dial in information below NEWARK, CA / ACCESS Newswire / June 26, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the ...

Johnson & Johnson (NYSE: JNJ) ranks among the top stocks for an early retirement portfolio. On June 13, Johnson & Johnson ...

Germany’s Formycon announced that Klinge Biopharma, the exclusive owner of the global commercialization rights of ...

Johnson & Johnson (NYSE:JNJ) is one of the 10 undervalued blue chip stocks analysts recommend for smart investing. On June 18 ...

DataM Intelligence | competitive Intelligence GA treatment market heats up: Syfovre & Izervay lead, while oral, gene, cell therapies and AI ...

Buying Dividend Aristocrats at bargain prices can be a winning investment strategy. Read about two such stocks that are ...

Updates on the initial dividend picks for 2025 and a few new names. David Harrell: Hi, I’m David Harrell, editor of ...